Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: SVF (Adipose Tissue Derived MSC) Based Therapy for CKD. [Phase 1, Phase 2]
Clinical trial update for adipose tissue–derived mesenchymal stem cell therapy (SVF) in chronic kidney disease, spanning Phase 1 and Phase 2…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) [Phase 3]
The EMPA-KIDNEY Phase 3 trial evaluating empagliflozin for heart and kidney protection in chronic kidney disease has completed with results …
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) [Phase 2]
Phase 2 trial updates for daprodustat (PHI) in anemia of CKD (ASCEND: Fe) have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Bicarbonate Administration in CKD [NA]
Clinical trial update on bicarbonate administration in chronic kidney disease with metabolic acidosis; the study is completed and results po…
-
FDA approval · 2023-07-24FDA Approved: BUMETANIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original ANDA for bumetanide, a loop diuretic used to treat edema and related conditions.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: The Effect of Cold Packs, Lidocaine and Flash Lights on Cannulation Pain in Hemodialysis Patients [Phase 3]
Phase 3 clinical trial evaluating cold packs, lidocaine, and flash lights to reduce cannulation pain at arteriovenous graft sites in hemodia…
-
FDA approval · 2023-07-11FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for sevelamer hydrochloride by Aurobindo Pharma Limited, establishing a generic version of the phosphate binde…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease [Phase 4]
A Phase 4 trial updating on the efficiency and safety of Paxlovid in COVID-19 patients with severe chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects [Phase 2]
Phase 2 clinical trial updates the effects of sitaxsentan on proteinuria, 24-hour blood pressure, and arterial stiffness in chronic kidney d…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Blood Pressure Lowering in Dialysis (BOLD) Trial [Phase 2]
Phase 2 trial investigating blood pressure lowering strategies in patients with end-stage renal disease on dialysis; trial completed with re…
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Evaluate the Effect and Safety of Pu Yang Wan Wu Tang and Western Medicine on Chronic Kidney Disease [Phase 2, Phase 3]
A clinical trial update investigating Pu Yang Wan Wu Tang in combination with Western medicine for chronic kidney disease across Phase 2 and…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Five, Plus Nuts and Beans for Kidneys [NA]
Clinical trial update for a Johns Hopkins study on nutrition (five, plus nuts and beans) in chronic kidney disease and hypertension; study c…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure [NA]
This clinical trial update notes termination of a study evaluating the InnAVasc Graft for dialysis access in patients with kidney failure, w…
-
FDA approval · 2023-06-15FDA Approved: DOXERCALCIFEROL — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved an original application for doxercalciferol as a generic drug, expanding access to this vitamin D analog.
-
FDA approval · 2023-06-06FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer carbonate from Sanofi-Aventis U.S. LLC, indicating an updated labeling for the product…
-
FDA approval · 2023-06-05FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution, submitted by Vantive US H…
-
FDA approval · 2023-05-26FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for sevelamer hydrochloride from Macleods Pharmaceuticals Limited, authorizing a generic phosphate bin…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine [Phase 2]
Phase 2 clinical trial evaluating N-acetylcysteine to reduce thrombotic phenotype in chronic kidney disease patients; the study is completed…
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease [Phase 2]
Phase 2 clinical trial investigating atorvastatin with alkali therapy in autosomal dominant polycystic kidney disease and chronic kidney dis…
-
FDA approval · 2023-05-19FDA Approved: SEVELAMER CARBONATE — Supplemental Application (DR. REDDY'S LABORATORIES LIMITED)
FDA approved a supplemental application for Sevelamer Carbonate submitted by Dr. Reddy's Laboratories Limited. Sevelamer carbonate is a phos…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome [Phase 3]
A Phase 3 trial comparing extended-release exenatide with placebo in diabetic patients with Type 4 cardiorenal syndrome has completed enroll…
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function. [Phase 1]
Phase 1 study assessing the pharmacokinetics and safety of apraglutide in participants with normal and impaired kidney function (Chronic Kid…
-
FDA approval · 2023-05-10FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) filed by Takeda Pharmaceuticals America, Inc., expanding the …
-
FDA approval · 2023-05-10FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2023-05-10FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) by Takeda Pharmaceuticals America, Inc.